These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28176473)

  • 21. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
.
    Lepori N; Cheungpasitporn W; Sethi S; Murray D; Kumar S; Leung N; Giridhar KV; Fervenza FC
    Clin Nephrol; 2018 Apr; 89(4):291-299. PubMed ID: 29249234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.
    Chauvet S; Frémeaux-Bacchi V; Petitprez F; Karras A; Daniel L; Burtey S; Choukroun G; Delmas Y; Guerrot D; François A; Le Quintrec M; Javaugue V; Ribes D; Vrigneaud L; Arnulf B; Goujon JM; Ronco P; Touchard G; Bridoux F
    Blood; 2017 Mar; 129(11):1437-1447. PubMed ID: 28069603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome.
    Cook HT
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):165-170. PubMed ID: 29517501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating C3 glomerulopathy with eculizumab.
    Welte T; Arnold F; Kappes J; Seidl M; Häffner K; Bergmann C; Walz G; Neumann-Haefelin E
    BMC Nephrol; 2018 Jan; 19(1):7. PubMed ID: 29329521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3 glomerulopathy.
    Mehdi A; Taliercio JJ
    Cleve Clin J Med; 2023 May; 90(6 suppl 1):e1-e4. PubMed ID: 37225259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with avacopan (CCX168) in a pediatric patient with C3 glomerulonephritis.
    Zotta F; Diomedi-Camassei F; Gargiulo A; Cappoli A; Emma F; Vivarelli M
    Pediatr Nephrol; 2023 Dec; 38(12):4197-4201. PubMed ID: 37306717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal gammopathy-associated proliferative glomerulonephritis.
    Sethi S; Rajkumar SV
    Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
    Sahin GM; Sahin S; Kantarci G; Ergin H
    Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
    He RJ; Xiao HJ; Wang SX; Guan N; Yao Y; Ding J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):939-43. PubMed ID: 23324154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.
    Koukoulaki M; Goumenos DS
    Expert Opin Investig Drugs; 2010 May; 19(5):673-87. PubMed ID: 20374037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of C3 glomerulopathy in a center of expertise.
    Koopman JJE; Teng YKO; Boon CJF; van den Heuvel LP; Rabelink TJ; van Kooten C; de Vries APJ
    Neth J Med; 2019 Jan; 77(1):10-18. PubMed ID: 30774098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilizing therapeutic drug monitoring to optimize therapy with eculizumab and mycophenolate mofetil in a child with C3 glomerulonephritis.
    Riedl Khursigara M; Chung E; Tjon J; Noone D; Chami R; Licht C; Teoh CW
    Pediatr Nephrol; 2023 Oct; 38(10):3483-3487. PubMed ID: 36884075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C3 glomerulopathy.
    Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
    Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare Case of C3 Glomerulopathy in a Patient of Type 1 Diabetes Mellitus.
    Godara S; Saraf KK
    Saudi J Kidney Dis Transpl; 2022 Feb; 33(Supplement):S83-S86. PubMed ID: 37102528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eculizumab for treatment of rapidly progressive C3 glomerulopathy.
    Le Quintrec M; Lionet A; Kandel C; Bourdon F; Gnemmi V; Colombat M; Goujon JM; Frémeaux-Bacchi V; Fakhouri F
    Am J Kidney Dis; 2015 Mar; 65(3):484-9. PubMed ID: 25530108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
    Gomes-Alves I; Castro-Ferreira I
    Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapidly progressing glomerulonephritis secondary to henoch-schonlein purpura treated with mycophenolate mofetil: a case report with atypical etiology and presentation.
    Muzaffar M; Taj A; Sethi N; Kaw D
    Am J Ther; 2010; 17(5):e163-6. PubMed ID: 19636243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations].
    Daugas E
    Rev Med Interne; 2008 Sep; 29(9):710-7. PubMed ID: 18565625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.